scispace - formally typeset
M

Maryam Mehrpour

Researcher at University of Paris

Publications -  11
Citations -  6406

Maryam Mehrpour is an academic researcher from University of Paris. The author has contributed to research in topics: Cancer research & Medicine. The author has an hindex of 3, co-authored 4 publications receiving 5083 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Daniel J. Klionsky, +2522 more
- 01 Jan 2016 - 
TL;DR: Author(s): Klionsky, DJ; Abdelmohsen, K; Abe, A; Abedin, MJ; Abeliovich, H; A Frozena, AA; Adachi, H, Adeli, K, Adhihetty, PJ; Adler, SG; Agam, G; Agarwal, R; Aghi, MK; Agnello, M; Agostinis, P; Aguilar, PV; Aguirre-Ghis
Journal ArticleDOI

circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer

Yun Ling, +17 more
- 03 Jan 2022 - 
TL;DR: In this paper , the authors identified a circRNA circCDYL2, which was overexpressed in trastuzumab-resistant patients, which conferred trastusumab resistance in breast cancer cells in vitro and in vivo.
Journal ArticleDOI

circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer

Yun Ling, +17 more
- 03 Jan 2022 - 
TL;DR: In this paper , the authors identified a circRNA circCDYL2, which was overexpressed in trastuzumab-resistant patients, which conferred trastusumab resistance in breast cancer cells in vitro and in vivo.